Back
Matthews Emerging Markets Ex Chn Act ETF Vs. PTC Therapeutics Industry Stock Comparison
Buy
61
MEMX
Matthews Emerging Markets Ex Chn Act ETF
Last Price:
29.70
Seasonality Move:
8.2%
Buy
51
PTCT
PTC Therapeutics
Last Price:
50.29
Seasonality Move:
17.12%
Buy
61
Matthews Emerging Markets Ex Chn Act ETF (MEMX)
is a Buy
Is Matthews Emerging Markets Ex Chn Act ETF a Buy, Sell or Hold?
- The current Matthews Emerging Markets Ex Chn Act ETF [MEMX] share price is $29.99. The Score for MEMX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- MEMX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $50.29. The Score for PTCT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PTCT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MEMX Stock Price Chart
What is Matthews Emerging Markets Ex Chn Act ETF's stock price today?
-
The Matthews Emerging Markets Ex Chn Act ETF share price today is $29.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEMX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $50.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.
MEMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 50.14 | Buy |
| Chaikin Money Flow: | 2402 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.6 - 30.26) | Buy |
| Bollinger Bands (100): | (29.66 - 30.86) | Sell |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.11 | Buy |
| Relative Strength Index (14 RSI): | 66.75 | Buy |
| Chaikin Money Flow: | -849912 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.04 - 46.16) | Buy |
| Bollinger Bands (100): | (32.47 - 41.53) | Buy |
MEMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.86 | Buy |
| 20-day SMA: | 29.85 | Buy |
| 50-day SMA: | 30.34 | Sell |
| 200-day SMA: | 29.74 | Buy |
| 8-day EMA: | 29.84 | Buy |
| 20-day EMA: | 29.91 | Buy |
| 50-day EMA: | 30.13 | Sell |
| 200-day EMA: | 29.54 | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.81 | Buy |
| 20-day SMA: | 43.67 | Buy |
| 50-day SMA: | 40.62 | Buy |
| 200-day SMA: | 34.19 | Buy |
| 8-day EMA: | 46.55 | Buy |
| 20-day EMA: | 44.07 | Buy |
| 50-day EMA: | 41.1 | Buy |
| 200-day EMA: | 35.83 | Buy |
Matthews Emerging Markets Ex Chn Act ETF Earnings Growth & MEMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.82 per share.
Matthews Emerging Markets Ex Chn Act ETF Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||